Skip to main content

Darwin Global Management, Ltd.

SEC CIK
0001839209
Latest filing
Aug 14, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Darwin Global Management, Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of MLTX by Darwin Global Management, Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−1,039,289−100.0%Sold outHolders
Q4 20231,039,289$62.8M12.3%+1,039,289NewHolders